Merited Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Merited Wealth's LLY Position: Q3 2026 in Review
Merited Wealth reduced its Eli Lilly (LLY) stake by 0.33% in Q3 2026, selling an estimated $3.54K and leaving 902 shares worth $1.04M. The position accounts for 0.72% of the portfolio, ranked #28.
Merited Wealth first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.09M in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Merited Wealth held 902 shares of Eli Lilly worth $1.04M as of Q3 2026.
- Merited Wealth sold 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
- Eli Lilly made up 0.72% of Merited Wealth's portfolio in Q3 2026, its #28 holding.
- Merited Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Merited Wealth's Eli Lilly position peaked at $1.09M in Q2 2026.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Merited Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.